Dispute resolution
Andrew Rima at Goldman Ismail Tomaselli Brennan & Baum LLP represents pharma companies and other manufacturers in complex product liability and mass tort litigation, serving as lead trial counsel in high-stakes federal and state cases. Rima’s national practice includes overseeing trial strategy and managing litigation teams across multiple jurisdictions for major life-sciences clients.
Legal 500 Editorial commentary
Accolades
Chicago Elite
Profile
Position
Partner
Career
Andrew is a trial and litigation lawyer who represents major corporations and individuals in sensitive, high-stakes matters that are disputed in court or arbitration. Andrew began his career representing indigent criminal defendants at a public defender's office, spending most of his days there inside a courtroom. He then joined Big Law before taking his trial skills to a nimble, trial-tested firm: Goldman Ismail. Andrew now concentrates on products liability, contract, securities, and patent cases.
Content supplied by Goldman Ismail Tomaselli Brennan & Baum LLP
Key clients
- Bayer AG
- Monsanto Company
Work highlights
Serving as national counsel for AbbVie in the testosterone-replacement therapy litigation, acting as lead trial counsel in the Rowley bellwether defence verdict and leading the resolution of all opt-out cases through trial-ready negotiations and strategic appellate work.